Product Information
MRT-83 is a drug candidate that has been shown to be active against leukemia cells, brain cancer cells, and breast cancer cells. MRT-83 binds to the cilium of human leukemia cells and inhibits the formation of hydrogen bonds. This leads to a disruption in the function of the cilium and subsequent cellular death. MRT-83 also binds to vitamin D3 in the body, which may lead to its clinical use in treating bone loss due to cancer treatment. Clinical development for MRT-83 is underway at this time.
Chemical properties
Technical inquiry about: 3D-NAC13192 MRT-83
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
